Internal Medicine, Pulmonary Disease · Kansas City, KS
NPI
1396814430
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3901 Rainbow Blvd
Kansas City, KS, 66160
Phone (913) 588-6046
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
790 services
Medicare patients, 2024
335
Average age 70
Drug cost, 2024
$3.8M
790 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joel D Mermis was code 94010 (pulmonary function testing), 115 times for 114 patients. In total Joel D Mermis billed 790 services in 31 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94010 Pulmonary Function Testing | Facility | 115 | 114 | $6.13 | $705 |
| 99233 Hospital E&M - Subsequent | Facility | 100 | 48 | $91.16 | $9,116 |
| 94729 Pulmonary Function Testing | Facility | 98 | 98 | $6.68 | $655 |
| 99291 Critical Care E&M | Facility | 83 | 36 | $160.15 | $13K |
| 94726 Pulmonary Function Testing | Facility | 80 | 80 | $9.10 | $728 |
| 99214 Office E&M - Established | Facility | 77 | 63 | $69.24 | $5,332 |
| 99232 Hospital E&M - Subsequent | Facility | 67 | 41 | $59.06 | $3,957 |
| 94727 Pulmonary Function Testing | Facility | 24 | 24 | $8.62 | $207 |
| 99215 Office E&M - Established | Facility | 19 | 14 | $87.71 | $1,667 |
| 94618 Pulmonary Function Testing | Facility | 18 | 18 | $17.11 | $308 |
| 99204 Office E&M - New | Facility | 17 | 17 | $78.06 | $1,327 |
| 99223 Hospital E&M - Initial | Facility | 13 | 13 | $127.68 | $1,660 |
By year: 2022 $51K for 698 services; 2023 $43K for 758 services; 2024 $44K for 790 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joel D Mermis prescribed most often to Medicare patients was Trikafta (Elexacaftor/Tezacaftor/Ivacaft), with 120 prescriptions and refills. In total Joel D Mermis wrote 790 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 120 | 120 | 12 | $2.9M |
| Azithromycin Generic | 81 | 135 | 23 | $1,540 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 81 | 125 | 17 | $81K |
| Breo Ellipta Fluticasone/Vilanterol | 43 | 45 | Under 11 | $18K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 42 | 68 | 25 | $1,897 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 40 | 50 | Under 11 | $31K |
| Creon Lipase/Protease/Amylase | 40 | 45 | Under 11 | $256K |
| Prednisone Generic | 24 | 25 | 14 | $54.12 |
| Pertzye Lipase/Protease/Amylase | 19 | 19 | Under 11 | $70K |
| Doxycycline Hyclate Generic | 18 | 18 | 13 | $124 |
| Ventolin Hfa Albuterol Sulfate | 18 | 27 | 11 | $1,653 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 17 | 21 | Under 11 | $9,699 |
| Levofloxacin Generic | 16 | 16 | 11 | $108 |
| Dupixent Pen Dupilumab | 15 | 15 | Under 11 | $56K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 15 | 15 | Under 11 | $6,737 |
Brand drugs: 524 claims; generic drugs: 266 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joel D Mermis $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.